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Saccharomyces cerevisiae is widely used as microbial cell factory in industrial biotechnology
due to its high tolerance to harsh industrial conditions. However, despite some progress 
over the last years, the development of optimized yeast strains for the production of 
chemicals and other materials is still a costly and time-consuming process, mainly due to 
the unavailability of suitable chassis cells.
In this work we propose a conceptual framework for the design of platform strains (Fig. 1A)
towards enhanced production of organic acids, which have found widespread applications 
in the food, chemical and pharmaceutical industries, by applying an OptGene-based 
metaheuristic approach [1, 2] and building upon the fact that these compounds are derived 
from the same metabolic precursors.
Several chassis strains containing common genetic deletions to fumarate, succinate and 
Lmalate, along with additional genetic targets to guarantee the desired phenotype, were 
generated and characterized in terms of its biological significance. Although wet lab 
experimental validation is still lacking, a chassis strain encompassing the non-intuitive 
inactivation of glucose-6-phosphate dehydrogenase (ZWF1) and 3-phosphoglycerate 
dehydrogenase isoenzymes (SER3/SER33), along with the inactivation of enzymes to 
disrupt the cyclic behavior of the tricarboxylic acid cycle and allow the respective compound 
excretion (Fig. 1B), was scored as an interesting candidate metabolic engineering strategy 
towards overproduction of the three C4-dicarboxylic acids, based on a multi-criteria 
systematic approach.
We hereby establish a proof-of-concept showing that is possible to generate pre-optimized 
platform strains for enhanced production of diverse organic acids. Furthermore, we foresee
that this model-driven modular design concept may constitute an important step towards 
realizing the full potential for the economical and sustainable production of other families of
industrially relevant chemicals.
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Figure 1. A - platform-strain design pipeline; B - overview of the in silico strain design for growth-coupled succinate 
production. Knockouts suggested by the developed strain design framework are shown in red font and reaction steps 
carrying no flux are shaded grey. The predicted flux is correlated with arrow width, while dashed lines represent 
lumped reactions.
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